Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

254-S

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
SummaryThe pharmacokinetics of (glycolato-0,0′)-diammine platinum (II) (254-S; NSC 375101D), one of the new platinum analogues… Expand
  • figure 1
  • figure 2
  • table 2
Is this relevant?
1992
1992
A phase II clinical study of 254-S, a new anticancer platinum complex for gastrointestinal cancers, was conducted by the 254-S… Expand
Is this relevant?
1992
1992
A late phase II clinical study of 254-S, a new anticancer platinum complex, for head and neck cancer was conducted by the 254-S… Expand
Is this relevant?
1992
1992
A phase II study of 254-S was conducted in 134 patients with gynecological malignancies by the gynecology section of the 254-S… Expand
Is this relevant?
1992
1992
A phase II clinical study of 254-S, a new anticancer platinum complex, for cervical cancer was conducted by the 254-S Cervical… Expand
Is this relevant?
1992
1992
A phase II clinical study of 254-S, a new anticancer platinum complex, for primary lung cancer was conducted by the 254-S Lung… Expand
Is this relevant?
1992
1992
An early phase II clinical study of 254-S, a new anticancer platinum complex, for head and neck cancer was conducted by the 254-S… Expand
Is this relevant?
1991
1991
A phase I study of cis-diammine(glycolato)platinum (254-S; NSC 375101D) was conducted in 15 patients with refractory or relapsing… Expand
  • figure 1
  • table 1
  • table 2
  • table 4
  • figure 2
Is this relevant?
1990
1990
The addition of a new compound containing platinum, 254-S, an antineoplastic agent, to medium had no effect on p-aminohippurate… Expand
Is this relevant?
1988
1988
(Glycolate-o,o') diammineplatinum (II) (254-S) is one of the platinum derivatives showing high activity against rodent solid… Expand
Is this relevant?